No Prescription |
 |
 | ||
|
Imigran Imitrex |
|
| ||
No Prescription » Prescription Drugs 9 » Imigran Imitrex Sumatriptan is used to treat the symptoms of migraine headaches (severe throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Sumatriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels in the brain and by stopping pain signals from being sent to the brain. Sumatriptan does not prevent migraine attacks.Sumatriptan is taken by injection just under your skin as soon as your migraine symptoms appear. You should feel relief of your symptoms within 1 hour (maybe within 10 minutes). If your symptoms then return after the first injection you may take a second injection after 1 hour. But do not use more than two injections in a 24-hour period. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take sumatriptan exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Sumatriptan comes in an autoinjection device so that you can self-inject this medication into your thigh or deltoid area (shoulder joint). Your doctor or pharmacist should show you how to load the injector and administer the medication. Also read the instruction pamphlet and be sure that you understand the correct injection technique before you use the autoinjector. Buy Imigran Imitrex and other Prescription Drugs 9 products online at Medstore. Buy Online at Medstore - Click Here!
About Imigran Imitrex: Product Type: Prescription Drugs 9 Imigran ( Imitrex Generic Sumatriptan ) Imigran (Imitrex Generic Sumatriptan) Imitrex Generic Sumatriptan 6mg/0.5ml 100mg 2 Tablets 50mg 2 Tablets 1 pre-filled inj Imitrex Generic Sumatriptan Imigran
View more Prescription Drugs 9 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
